Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1124 (LINC01124)

Target
LINC01124
Molecular classification
Long noncoding RNA (lncRNA), Competing endogenous RNA (ceRNA), Other
01

Overview

Long intergenic non-protein coding RNA 1124 (LINC01124) is a long noncoding RNA gene located at chromosome 2q31.1 and typically contains a single exon[3]. LINC01124 is part of the lncRNA class, which do not encode proteins but regulate gene expression mainly through interactions with microRNAs and other biomolecules. Studies have shown LINC01124 is upregulated in several tumor types, such as hepatocellular carcinoma and colon cancer, where its overexpression promotes cell proliferation, migration, and invasion by acting as a competing endogenous RNA (ceRNA) that "sponges" microRNAs such as miR-1247-5p and miR-654-5p, leading to increased expression of oncogenic proteins like FOXO3 and HAX-1[1][2][4]. Conversely, LINC01124 appears downregulated in non-small cell lung cancer, where enforced expression suppresses proliferation and migration, indicating a potential tumor suppressor role in this context[3]. Its dysregulation in cancers makes it a candidate biomarker and possible therapeutic target in oncology, though no drugs directly target LINC01124 to date[1][2][3][4].

Other names
LINC01124long noncoding RNA 01124long non-coding RNA 01124
02

Mechanism of action

Sponges microRNAs (e.g., miR-1247-5p in hepatocellular carcinoma, miR-654-5p in colon cancer) and regulates gene expression via ceRNA mechanism.

03

Biological functions

Regulation of cell proliferationRegulation of cell migrationRegulation of cell invasionModulation of apoptosisMicroRNA sponging (acts as a ceRNA)Other
04

Disease associations

CancerHepatocellular carcinomaColon cancerNon-small cell lung cancerOther
05

Biomarkers

High expression as potential biomarker for hepatocellular carcinoma aggressivenessDownregulation as potential biomarker for metastatic risk in non-small cell lung cancer

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1124 (LINC01124).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1124 (LINC01124).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call